Go Pro

Alex Stranahan Analyst Performance

Analyst at Bank of America

Alex Stranahan is a stock analyst at Bank of America in the healthcare sector, covering 2 publicly traded companies. Over the past year, Alex Stranahan has issued 2 stock ratings, including and buy recommendations. While full access to Alex Stranahan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Alex Stranahan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 4 Years
Buy Recommendations
50.00% 1 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%1 ratings
Hold50.0%1 ratings
Sell0.0%0 ratings

Out of 2 total stock ratings issued by Alex Stranahan at Bank of America, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
2 companies

Alex Stranahan, an analyst at Bank of America, currently covers 2 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
2 companies
100.0%

Alex Stranahan of Bank of America specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
2 companies
100.0%

Alex Stranahan's Ratings History at Bank of America

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
8/14/2026Lower Price Target$3.42$6.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
10/17/2025Set Price Target$54.27$80.00